Michael A. Incze
( out of 120 reviews )

Michael A. Incze, MD, MSEd

Languages spoken: English

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000
Directions

  • Dr. Michael Incze is a primary care physician in the Division of General Internal Medicine who is board certified in internal medicine and addiction medicine. His clinical interests include patient education, high value care, and caring for vulnerable populations including people experiencing homelessness and people with substance use disorders. He regularly volunteers at the Fourth Street Clinic, a federally qualified health center that specialized in providing care to people experiencing homelessness. He is a volunteer physician at the Rosebud Indian Health Service hospital in South Dakota. He also founded a clinic that focuses on providing primary care-based addiction treatment at Sugarhouse Health Center.

    Outside of clinical practice, Dr. Incze is involved in several research, quality improvement, and educational initiatives aimed at improving care for patients with chronic pain and substance use disorders. He serves as a faculty member at the school of medicine and mentors medical students, residents, and fellows. He is also interested in medical writing and has authored numerous commentaries that have appeared in top-tier medical journals. He is the current patient page editor for JAMA Internal Medicine.

    Dr. Incze attended medical school at University of California, Davis and residency at the University of California, San Francisco. In his free time he enjoys cycling, cooking, travelling, and composing music.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Preventive Medicine (Addiction Medicine)

    Patient Rating

    4.9 /5
    ( out of 120 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 02, 2025
    SUGAR HOUSE HEALTH CENTER

    hi Mike!

    December 16, 2024
    SUGAR HOUSE HEALTH CENTER

    Did and dos a good job

    December 12, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Incze is always mentally present with me, offering his educated perspective on any questions I ask. He carefully lays out options, discussing the pros and cons of each option. Then at each visit we revisit my selections to see if we can do even better for the future.

    October 31, 2024
    SUGAR HOUSE HEALTH CENTER

    He was amazing and so calm, caring and very good at listening

    October 29, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr Incze answered my questions and concerns regarding my treatments and recommendations.

    October 09, 2024
    SUGAR HOUSE HEALTH CENTER

    He is very thorough and helpful.

    June 19, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Incze has been a critical part of my recovery! He is always extremely understanding, compassionate, caring, and always puts my care above all! I would HIGHLY recommend him!!!

    June 14, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Incze is the best! He's a great listener, involves you in making decisions about your care, and is genuinely interested in your wellbeing.

    June 11, 2024
    SUGAR HOUSE HEALTH CENTER

    I can't tell any more people about how excellent Dr. Incze is. Too many people are finding out how good he is and it's hard to get to see him anymore.

  • Dr. Michael Incze is a primary care physician in the Division of General Internal Medicine who is board certified in internal medicine and addiction medicine. His clinical interests include patient education, high value care, and caring for vulnerable populations including people experiencing homelessness and people with substance use disorders. He regularly volunteers at the Fourth Street Clinic, a federally qualified health center that specialized in providing care to people experiencing homelessness. He is a volunteer physician at the Rosebud Indian Health Service hospital in South Dakota. He also founded a clinic that focuses on providing primary care-based addiction treatment at Sugarhouse Health Center.

    Outside of clinical practice, Dr. Incze is involved in several research, quality improvement, and educational initiatives aimed at improving care for patients with chronic pain and substance use disorders. He serves as a faculty member at the school of medicine and mentors medical students, residents, and fellows. He is also interested in medical writing and has authored numerous commentaries that have appeared in top-tier medical journals. He is the current patient page editor for JAMA Internal Medicine.

    Dr. Incze attended medical school at University of California, Davis and residency at the University of California, San Francisco. In his free time he enjoys cycling, cooking, travelling, and composing music.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Adult Psychiatry
    General Medicine
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Preventive Medicine (Addiction Medicine)

    Education history

    Residency Internal Medicine - University of California, San Francisco Resident
    Professional Medical Medicine - University of California, Davis School of Medicine M.D.
    Graduate Training Pace University M.S.Ed.
    Undergraduate Major: Biology; Minor: Chemistry - University of Utah B.A.

    Selected Publications

    Journal Article

    1. Incze MA, Anderson TS (2025). Integrating Buprenorphine Into Chronic Pain Treatment-Putting the Choice in VOICE. JAMA Intern Med. (Read full article)
    2. Kneifati-Hayek JZ, Incze MA (2024). Reducing Unnecessary Admissions in the Emergency Department. JAMA Intern Med. (Read full article)
    3. Incze MA, Simon C, Suen LW (2024). Methadone's Moment. JAMA, 332(23), 1969-1970. (Read full article)
    4. Incze MA, Zhang GY (2024). Clarifying the Risks of Consuming Edible Cannabis-Reply. JAMA Intern Med, 184(12), 1479-1480. (Read full article)
    5. Incze MA, Huebler S, Szczotka K, Grant S, Kertesz SG, Gordon AJ (2024). Expert Panel Consensus on the Effectiveness and Implementation of Models to Support Posthospitalization Care Transitions for People With Substance Use Disorders. J Addict Med. (Read full article)
    6. Johnson TA, Incze MA, Silverstein WK (2024). Heightened Vigilance Needed When Patients Are Prescribed GLP-1 and GIP Agonists. JAMA Intern Med. (Read full article)
    7. Kelley AT, Incze MA, Baumgartner M, Campbell ANC, Nunes EV, Scharfstein DO (2024). Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders. Drug Alcohol Depend, 261, 111368. (Read full article)
    8. Incze MA, Stolebarger L (2024). On Her Own Two Feet. N Engl J Med, 391(2), 105-107. (Read full article)
    9. Bogler O, Incze MA (2024). Endocrine Adverse Effects of Long-Term Opioid Use. JAMA Intern Med, 184(7), 831-832. (Read full article)
    10. Zhang GY, Incze MA (2024). I Am Curious About Cannabis Edibles-What Should I Know? JAMA Intern Med. (Read full article)
    11. Incze MA, Huebler S, Grant S, Gordon AJ (2024). Using the Delphi Process to Prioritize an Agenda for Care Transition Research for Patients With Substance Use Disorders. Subst Use Addctn J, 45(3), 29767342241246762. (Read full article)
    12. Incze MA, Huebler S, Chen D, Stofko A, Wu C, Baylis JD, Wells C, Babbel D (2024). Hospitalists' Attitudes and Experiences With Posthospitalization Care Transitions for Patients With Substance Use Disorders: A Cross-sectional Analysis. J Addict Med. (Read full article)
    13. Incze MA, Covinsky KE, Inouye SK (2024). Introducing the Expanded JAMA Internal Medicine Editorial Fellowship. JAMA Intern Med, 184(3), 241. (Read full article)
    14. Zhang GY, Incze MA (2024). I Am Worried I Have Sciatica-What Do I Need to Know? JAMA Intern Med, 184(1), 122. (Read full article)
    15. Incze MA, Azari S, Finnell DS (2023). Amplifying the Strength and Leadership of Nurses in Opioid Use Disorder Care-Loud and PROUD. JAMA Intern Med, 183(12), 1354-1356. (Read full article)
    16. Incze MA, Grady D, Inouye SK (2023). Announcing Expanded Content for Clinicians Through the Clinical Review and Education Section at JAMA Internal Medicine. JAMA Intern Med. (Read full article)
    17. Incze MA, Chen D, Galyean P, Kimball ER, Stolebarger L, Zickmund S, Gordon AJ (2023). Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study. J Addict Med, 17(4), 401-406. (Read full article)
    18. Incze MA, Sehgal SL, Hansen A, Garcia L, Stolebarger L (2023). Evaluation of a Primary Care-Based Multidisciplinary Transition Clinic for Patients Newly Initiated on Buprenorphine in the Emergency Department. Subst Abus, 44(3), 220-225. (Read full article)
    19. Zhang GY, Incze MA (2023). What Should I Know About Hormones for Symptoms of Menopause? JAMA Intern Med. (Read full article)
    20. Zhang GY, Incze MA (2023). What Should I Know About Stopping Routine Cancer Screening? JAMA Intern Med. (Read full article)
    21. Incze MA, Kelley AT, Singer PM (2023). Implementing the White House's Strategic Plan to Save Lives Amid the Opioid Crisis: Reaching for the "North Star". JAMA, 329(9), 705-706. (Read full article)
    22. Incze MA (2023). Redesigning Opioid Pain Agreements to Promote Patient-Centered Care. JAMA Intern Med, 183(3), 179-180. (Read full article)
    23. Incze MA, Kelley AT, Johnson K (2022). Reexamining Medicaid Patient Review and Restriction Programs Amid the Evolving Opioid Epidemic. JAMA Intern Med. (Read full article)
    24. Parks AL, Incze MA (2022). What Can At-home Genetic Tests Tell Me About My Health? JAMA Intern Med, 182(6), 691. (Read full article)
    25. Incze MA, Kelley AT, Singer PM (2021). Heterogeneous State Cannabis Policies: Potential Implications for Patients and Health Care Professionals. JAMA, 326(23), 2363-2364. (Read full article)
    26. Incze MA (2021). Reassessing the Role of Routine Urine Drug Screening in Opioid Use Disorder Treatment. JAMA Intern Med, 181(10), 1282-1283. (Read full article)
    27. Incze MA (2021). Should I Get a Coronary CT Scan? JAMA Intern Med, 181(5), 732. (Read full article)
    28. Incze MA (2021). At the Cusp - Reimagining Infective Endocarditis Care amid the Opioid Epidemic. N Engl J Med, 384(4), 297-299. (Read full article)
    29. Incze MA, Tobey ML, Sequist TD (2020). Investing in the Health of American Indians and Alaska Natives. JAMA Intern Med, 180(5), 633-634. (Read full article)
    30. Incze MA, Slawek D, Cunningham CO (2020). What Should I Know About Medical Cannabis? JAMA Intern Med, 180(4), 624. (Read full article)
    31. Landefeld J, Incze MA (2019). Advance Care Planning-What Should I Know? JAMA Intern Med, 180(1), 172. (Read full article)
    32. Incze MA (2019). I'm Worried About Depression-What Should I Know? JAMA Intern Med, 179(11), 1612. (Read full article)
    33. Incze MA (2019). I Have Arthritis of the Knees: What Should I Do? JAMA Intern Med, 179(5), 736. (Read full article)
    34. Keshvani N, Gupta A, Incze MA (2018). I Am Worried About Gonorrhea: What Do I Need to Know? JAMA Intern Med, 179(1), 132. (Read full article)

    Review

    1. Franks L, Cochran G, Reeves C, Incze MA, Hardy CJ, Gordon AJ, Kelley AT (2024). Evaluations of State Medical Cannabis Programs in the USA: A Narrative Review. [Review]. Med Cannabis Cannabinoids, 7(1), 243-256. (Read full article)
    2. Incze MA, Kelley AT, James H, Nolan S, Stofko A, Fordham C, Gordon AJ (2024). Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy. [Review]. J Gen Intern Med, 39(5), 837-846. (Read full article)
    3. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JFP (2022). Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. [Review]. Subst Abus, 43(1), 1286-1299. (Read full article)
    4. Dickman S, Mirza R, Kandi M, Incze MA, Dodbiba L, Yameen R, Agarwal A, Zhang Y, Kamran R, Couban R, Guyatt G, Hanna S (2020). Mortality at For-Profit Versus Not-For-Profit Hemodialysis Centers: A Systematic Review and Meta-analysis. [Review]. Int J Health Serv, 51(3), 371-378. (Read full article)

    Commentary

    1. Incze MA (2021). Necessity of Coronary CT Scans-Reply. JAMA Intern Med, 181(9), 1259. (Read full article)

    Editorial

    1. Incze MA, Garland EL (2023). Mobilizing Primary Care Against the Opioid Crisis in the Post X-Waiver Era. J Gen Intern Med, 38(16), 3618-3620. (Read full article)
    2. Incze MA, Parks AL, Stern RJ (2022). Teaching a Deeper Understanding of the Medical Literature. J Gen Intern Med, 38(4), 1059-1060. (Read full article)
    3. Incze MA, Kelley AT, Gordon AJ (2022). Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment. J Gen Intern Med, 37(7), 1771-1773. (Read full article)
    4. Incze MA, Kelley AT, Gordon AJ (2021). Improving Opioid Use Disorder Treatment through Quality Assessment. J Gen Intern Med, 36(9), 2820-2822. (Read full article)

    Letter

    1. Incze MA, Kelley T, Singer PM (2023). The White House's Strategic Plan to Address the Opioid Crisis-Reply. [Letter to the editor]. JAMA, 329(24), 2195. (Read full article)
    2. Kelley AT, Incze MA (2022). The need for a more inclusive and objective approach in developing a core outcomes set for opioid use disorder. [Letter to the editor]. Addiction, 118(1), 194-195. (Read full article)
    3. Incze MA, Slawek D, Cunningham CO (2020). The Importance of Pediatric Safety in Tetrahydrocannabinol Education-Reply. [Letter to the editor]. JAMA Intern Med, 180(7), 1027. (Read full article)

    Other

    1. Warrier G, Incze MA (2021). I Want to Lose Weight: Which Diet Is Best? JAMA Intern Med (181(9), p. 1268). United States. (Read full article)
    2. Incze MA, Kompala T (2020). I'm Worried About Low Testosterone-What Should I Know? JAMA Intern Med (180(6), p. 920). United States. (Read full article)